These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease. Guzmán-Vélez E; Jaimes S; Aguirre-Acevedo DC; Norton DJ; Papp KV; Amariglio R; Rentz D; Baena A; Henao E; Tirado V; Muñoz C; Giraldo M; Sperling RA; Lopera F; Quiroz YT J Alzheimers Dis; 2018; 65(1):107-115. PubMed ID: 30040714 [TBL] [Abstract][Full Text] [Related]
6. Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease. Martinez JE; Pardilla-Delgado E; Guzmán-Vélez E; Vila-Castelar C; Amariglio R; Gatchel J; Aguirre-Acevedo DC; Bocanegra Y; Baena A; Henao E; Tirado V; Muñoz C; Giraldo-Chica M; Lopera F; Quiroz YT J Int Neuropsychol Soc; 2022 Jul; 28(6):541-549. PubMed ID: 34187609 [TBL] [Abstract][Full Text] [Related]
7. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558 [TBL] [Abstract][Full Text] [Related]
8. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease. Vila-Castelar C; Muñoz N; Papp KV; Amariglio RE; Baena A; Guzmán-Vélez E; Bocanegra Y; Sanchez JS; Reiman EM; Johnson KA; Sperling RA; Lopera F; Rentz DM; Quiroz YT Alzheimers Res Ther; 2020 Sep; 12(1):104. PubMed ID: 32912283 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. Vila-Castelar C; Tariot PN; Sink KM; Clayton D; Langbaum JB; Thomas RG; Chen Y; Su Y; Chen K; Hu N; Giraldo-Chica M; Tobón C; Acosta-Baena N; Luna E; Londoño M; Ospina P; Tirado V; Muñoz C; Henao E; Bocanegra Y; Alvarez S; Rios-Romenets S; Ghisays V; Goradia D; Lee W; Luo J; Malek-Ahmadi MH; Protas HD; Lopera F; Reiman EM; Quiroz YT; Alzheimers Dement; 2022 Nov; 18(11):2272-2282. PubMed ID: 35103388 [TBL] [Abstract][Full Text] [Related]
10. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial. Rios-Romenets S; Lopera F; Sink KM; Hu N; Lian Q; Guthrie H; Smith J; Cho W; Mackey H; Langbaum JB; Thomas RG; Giraldo-Chica M; Tobon C; Acosta-Baena N; Muñoz C; Ospina P; Tirado V; Henao E; Bocanegra Y; Chen K; Su Y; Goradia D; Thiyyagura P; VanGilder PS; Luo J; Ghisays V; Lee W; Malek-Ahmadi MH; Protas HD; Chen Y; Quiroz YT; Reiman EM; Tariot PN; Alzheimers Dement; 2020 Jul; 16(7):1023-1030. PubMed ID: 32418361 [TBL] [Abstract][Full Text] [Related]